Pre-clinical studies of 2'-fluoro-5-[C-11]-methyl-1-beta-D-arabinofuranosyluracil (FMAU): A potential PET indicator of tumor proliferation.

被引:0
|
作者
Conti, PS
Anderson, JH
Wong, DF
Bading, JR
Alauddin, MM
Ravert, HT
MAtthews, WB
Musachio, JL
Dannals, RF
Scheffel, U
机构
[1] UNIV SO CALIF,LOS ANGELES,CA 90033
[2] JOHNS HOPKINS MED INST,BALTIMORE,MD 21205
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:419 / 419
页数:1
相关论文
共 30 条
  • [21] Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice
    Jadvar, Hossein
    Park, Ryan
    Yap, Li-Peng
    Chen, Kai
    Hughes, Lindsey
    Conti, Peter
    ANTICANCER RESEARCH, 2017, 37 (02) : 475 - 479
  • [22] Evaluation of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-l-arabinofuranosyluracil ([18F]-l-FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-d-FMAU and [18F]FLT
    Ryuichi Nishii
    Andrei Y. Volgin
    Osama Mawlawi
    Uday Mukhopadhyay
    Ashutosh Pal
    William Bornmann
    Juri G. Gelovani
    Mian M. Alauddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 990 - 998
  • [23] Evaluation of 2′-deoxy-2′-[18F] fluoro-5-methyl-1-β-L-arabinofuranosyluracil ([18F]-L-FMAU) as a PET imaging agent for cellular proliferation:: comparison with [18F]-D-FMAU and [18F]FLT
    Nishii, Ryuichi
    Volgin, Andrei Y.
    Mawlawi, Osama
    Mukhopadhyay, Uday
    Pal, Ashutosh
    Bornmann, William
    Gelovani, Juri G.
    Alauddin, Mian M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 990 - 998
  • [24] Synthesis and in vivo studies of 2′-Deoxy-2′-[18F]-fluoro-5-bromo-1-β-D-arabinofuranosyluracil ([18F]-FBAU) and 2′-deoxy-2′-[18f]-fluoro-5-chloro-1-β-D-arabinofuranosyluracil ([18F]-FCAU) in tumor-bearing mice as potential PET imaging agents.
    Alauddin, MM
    Shahinian, A
    Fissekis, JD
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 296P - 296P
  • [25] NUCLEOSIDES .146. 1-METHYL-5-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)URACIL, THE C-NUCLEOSIDE ISOSTERE OF THE POTENT ANTIVIRAL AGENT 1-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)THYMINE (FMAU) - STUDIES DIRECTED TOWARD THE SYNTHESIS OF 2'-DEOXY-2'-SUBSTITUTED ARABINO NUCLEOSIDES .6.
    PANKIEWICZ, KW
    NAWROT, B
    GADLER, H
    PRICE, RW
    WATANABE, KA
    JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (12) : 2314 - 2316
  • [26] PHASE-I CLINICAL-TRIAL OF 2'-FLUORO-5-METHYL-1-BETA-ARABINO-FURANOSYLURACIL, (FMAU), A NEW ANTIVIRAL AGENT ACTIVE AGAINST ARA-C RESISTANT MURINE LEUKEMIA
    FANUCCHI, M
    LEYLANDJONES, B
    BURCHENAL, J
    YOUNG, C
    CLARKSON, B
    LOPEZ, C
    NIELSON, S
    PHILIPS, F
    WATANABE, K
    FOX, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 150 - 150
  • [27] SYNTHESIS AND INVIVO CHARACTERIZATION OF D-(+)-(N1-[C-11]METHYL)-2-BR-LSD - A RADIOLIGAND FOR POSITRON EMISSION TOMOGRAPHIC STUDIES OF SEROTONIN 5-HT2 RECEPTORS
    LEVER, JR
    DANNALS, RF
    WILSON, AA
    RAVERT, HT
    SCHEFFEL, U
    HOFFMAN, BJ
    HARTIG, PR
    WONG, DF
    WAGNER, HN
    NUCLEAR MEDICINE AND BIOLOGY, 1989, 16 (07): : 697 - 704
  • [28] Synthesis of [11C]methyl 3-((2,2-difluoro-5H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-d]imidazol-6-yl)carbamoyl)benzoate as a new potential PET agent for imaging of casein kinase 1
    Gao, Mingzhang
    Wang, Min
    Zheng, Qi-Huang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [29] Synthesis and preliminary biological evaluation of [11C] methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-D-leucinate as a new potential PET radioligand for the fractalkine receptor (CX3CR1)
    Gao, Mingzhang
    Wang, Min
    Meyer, Jill
    Peters, Jonathan
    Zarrinmayeh, Hamideh
    Territo, Paul
    Hutchins, Gary
    Zheng, Qi-Huang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [30] Antitumor imidazotetrazines.: 40.: Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies
    Brown, GD
    Luthra, SK
    Brock, CS
    Stevens, MFG
    Price, PM
    Brady, F
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (25) : 5448 - 5457